(Reuters) -Private equity firm GTCR can move forward with its acquisition of medical device coatings maker Surmodics’, a federal judge in Chicago ruled on Monday, rejecting the U.S. Federal Trade Commission’s bid to block the deal.
The FTC sued to block the deal in March in its first lawsuit to block a merger during President Donald Trump’s second term.
(Reporting by Jody Godoy in New York; Editing by Chris Reese)
Brought to you by www.srnnews.com
